These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15806571)

  • 1. Availability of conjugated ganglioside GD2 monoclonal antibody.
    Warzynski MJ; Roys JL; Peterson JW; DeLa Vega H
    Cytometry B Clin Cytom; 2005 May; 65(1):42-3. PubMed ID: 15806571
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.
    Warzynski MJ; Graham DM; Axtell RA; Higgins JV; Hammers YA
    Cytometry; 2002 Dec; 50(6):298-304. PubMed ID: 12497591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
    Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
    Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro photothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody.
    Wang CH; Huang YJ; Chang CW; Hsu WM; Peng CA
    Nanotechnology; 2009 Aug; 20(31):315101. PubMed ID: 19597244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
    Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
    Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
    Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
    Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic characterization of CD34(pos) cells.
    Keeney M; Brown W; Gratama J; Papa S; Lanza F; Sutherland DR;
    J Biol Regul Homeost Agents; 2003; 17(3):254-60. PubMed ID: 14524611
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
    Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.
    Saito M; Yu RK; Cheung NK
    Biochem Biophys Res Commun; 1985 Feb; 127(1):1-7. PubMed ID: 2579648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
    Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J
    Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200
    [No Abstract]   [Full Text] [Related]  

  • 11. Titering antibodies.
    Stewart CC; Stewart SJ
    Curr Protoc Cytom; 2001 May; Chapter 4():Unit 4.1. PubMed ID: 18770707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In the realm for standardization in immunophenotyping.
    Tárnok A
    Cytometry A; 2012 Nov; 81(11):931-2. PubMed ID: 23090894
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma.
    Ifversen MR; Kågedal B; Christensen LD; Rechnitzer C; Petersen BL; Heilmann C
    Int J Oncol; 2005 Jul; 27(1):121-9. PubMed ID: 15942651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.
    Heiss P; Bernatz S; Bruchelt G; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3177-8. PubMed ID: 9329630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Setting up and calibration of a flow cytometer for multicolor immunophenotyping.
    Kraan J; Gratama JW; Keeney M; D'Hautcourt JL
    J Biol Regul Homeost Agents; 2003; 17(3):223-33. PubMed ID: 14524607
    [No Abstract]   [Full Text] [Related]  

  • 16. Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.
    Cheung NK; Miraldi FD
    Prog Clin Biol Res; 1988; 271():595-604. PubMed ID: 3406022
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiparameter flow cytometry.
    Stewart CC
    J Immunoassay; 2000; 21(2-3):255-72. PubMed ID: 10929889
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing a multicolor immunophenotyping assay.
    Mahnke YD; Roederer M
    Clin Lab Med; 2007 Sep; 27(3):469-85, v. PubMed ID: 17658403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoradionuclide localization of human neuroblastoma xenografted in nude mice using anti-GD2 labelled with I125].
    Perdereau B; Barbaroux C; Michon J; Fridman WH; Rosin N; Validire P; Zucker JM; Manil L
    Bull Cancer; 1994 Jul; 81(7):593-8. PubMed ID: 7742601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: guideline from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
    Schnizlein-Bick CT; Mandy FF; O'Gorman MR; Paxton H; Nicholson JK; Hultin LE; Gelman RS; Wilkening CL; Livnat D
    Cytometry; 2002 Apr; 50(2):46-52. PubMed ID: 12116345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.